Personal information

No personal information available

Activities

Collapse all

Employment (2)

GlaxoSmithKline Plc: Stevenage, London, GB

2016-06-06 to present | Lab Manager
Employment
Source: Self-asserted source
Jo Bramhall

University of Cambridge: Cambridge, Cambridgeshire, GB

2009-06-04 to 2016-06-03 | Cell Biologist (Cancer Research UK Cambridge Institute)
Employment
Source: Self-asserted source
Jo Bramhall

Works (10)

Prediction and identification of synergistic compound combinations against pancreatic cancer cells

iScience
2021-09 | Journal article
DOI: 10.1016/j.isci.2021.103080
Contributors: Yasaman KalantarMotamedi; Ran Joo Choi; Siang-Boon Koh; Jo L. Bramhall; Tai-Ping Fan; Andreas Bender
Source: check_circle
Crossref

Combenefit: an interactive platform for the analysis and visualization of drug combinations

Bioinformatics
2016-04 | Journal article
DOI: 10.1093/bioinformatics/btw230
Contributors: Giovanni Y. Di Veroli; Chiara Fornari; Dennis Wang; Séverine Mollard; Jo L. Bramhall; Frances M. Richards; Duncan I. Jodrell
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

An automated fitting procedure and software for dose-response curves with multiphasic features

Sci. Rep.
2015-10-01 | Journal article
DOI: 10.1038/srep14701
Contributors: Giovanni Y. Di Veroli; Chiara Fornari; Ian Goldlust; Graham Mills; Siang Boon Koh; Jo L Bramhall; Frances M. Richards; Duncan I. Jodrell
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

The EGFR demonstrates linear signal transmission

Integr. Biol.
2014-06 | Journal article
DOI: 10.1039/c4ib00062e
Contributors: Diego A. Oyarzún; Jo L. Bramhall; Fernando López-Caamal; Frances M. Richards; Duncan I. Jodrell; Ben-Fillippo Krippendorff
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

PLoS ONE
2013-06 | Journal article
DOI: 10.1371/journal.pone.0067330
Contributors: Aurélie Courtin; Frances M. Richards; Tashinga E. Bapiro; Jo L. Bramhall; Albrecht Neesse; Natalie Cook; Ben-Fillippo Krippendorff; David A. Tuveson; Duncan I. Jodrell; Hana Algül
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells.

British journal of cancer
2012-10 | Journal article
DOI: 10.1038/bjc.2012.450
PMID: 23037716
PMC: PMC3493865
Contributors: Lin Y; Richards FM; Krippendorff BF; Bramhall JL; Harrington JA; Bapiro TE; Robertson A; Zheleva D; Jodrell DI
Source: Self-asserted source
Jo Bramhall via Europe PubMed Central

Abstract 1924: The aurora kinase inhibitor CYC3 synergizes with low concentrations of paclitaxel in pancreatic cancer cells in vitro

Cancer Res
2012-04 | Journal article
DOI: 10.1158/1538-7445.am2012-1924
Contributors: Yao Lin; Ben-Fillippo Krippendorff; Jo Bramhall; Tashinga Bapiro; Frances Richards; Duncan Jodrell; Daniella Zheleva
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

Abstract 3771: Capecitabine pharmacokinetics and efficacy in spontaneous tumors occurring in a genetically engineered mouse model (GEMM) of pancreatic cancer

Cancer Res
2012-04 | Journal article
DOI: 10.1158/1538-7445.am2012-3771
Contributors: Aurelie Courtin; Frances M. Richards; Tashinga E. Bapiro; Donna-Michelle Smith; Michael Williams; Jo L. Bramhall; Kristopher Frese; David A. Tuveson; Duncan I. Jodrell
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

Abstract 5446: The activity and pharmacokinetics of capecitabine in a mouse model (K8484) of pancreatic adenocarcinoma

Cancer Res
2011-04 | Journal article
DOI: 10.1158/1538-7445.am2011-5446
Contributors: Frances M. Richards; Aurelie Courtin; Tashinga E. Bapiro; Jo L. Bramhall; Natalie Cook; Kristopher K. Frese; David A. Tuveson; Duncan I. Jodrell
Source: Self-asserted source
Jo Bramhall via Crossref Metadata Search

Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan).

Drug metabolism and disposition: the biological fate of chemicals
2006-03 | Journal article
DOI: 10.1124/dmd.105.008185
PMID: 16531474
Contributors: Baldwin SJ; Bramhall JL; Ashby CA; Yue L; Murdock PR; Hood SR; Ayrton AD; Clarke SE
Source: Self-asserted source
Jo Bramhall via Europe PubMed Central
How many people are using ORCID?